Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleus

Neuroendocrinology

Volumn 68, Issue 2, 1998, Pages 89-97

  Legradi, Gabor ^a   Emerson, Charles H ^d   Ahima, Rexford S ^b   Rand, William M ^c   Flier, Jeffrey S ^b   Lechan, Ronald M ^a,c  

^a TUFTS MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Fasting; In situ hybridization; Leptin; Molecular neuroendocrinology; Monosodium glutamate; Paraventricular nucleus; Thyroid; Thyrotropin releasing hormone

Indexed keywords

CORTICOSTERONE; GLUTAMATE SODIUM; HORMONE RECEPTOR; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; THYROID HORMONE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIET RESTRICTION; FEEDBACK SYSTEM; GENE EXPRESSION; HOMEOSTASIS; HORMONE BLOOD LEVEL; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; IMAGE ANALYSIS; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANIMALS; ARCUATE NUCLEUS; BODY WEIGHT; CORTICOSTERONE; FASTING; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IN SITU HYBRIDIZATION; LEPTIN; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTEIN PRECURSORS; PROTEINS; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THYROID GLAND; THYROTROPIN-RELEASING HORMONE;

EID: 0031824260     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054354     Document Type: Article

References (70)

1. Lechan RM, Kakucska I: Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus; in Functional Anatomy of the Neuroendocrine Hypothalamus. Wiley, Chichester, 1992, pp 144-164.
2. Lechan RM: Update on thyrotropin-releasing hormone. Thyroid Today 1993;16/1:1-12.
3. Segerson TP, Kauer J, Wolfe HC, Mobtaker H, Wu P, Jackson IMD, Lechan RM: Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 1987;238:78-80.
4. Dyess EM, Segerson TP, Liposits Z, Paull WK, Kaplan MM, Wu P, Jackson IMD, Lechan RM: Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology 1988; 123:2291-2297.
5. Koller KJ, Wolff RS, Warden MK, Zoeller RT: Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci USA 1987; 84:7329-7333.
6. Kakucska I, Rand W, Lechan RM: Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by triiodothyronine and thyroxine. Endocrinology 1992; 130:2845-2850.
7. Rondeel JM, de Greef WJ, Klootwijk W, Visser TJ: Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats. Endocrinology 1992;130:651-656.
8. Wang PS, Huang S-W, Tung Y-F, Pu H-F, Tsai S-C, Lau C-P, Chien EJ, Chien C-H: Interrelationship between thyroxine and estradiol on the secretion of thyrotropin-releasing hormone and dopamine into hypophysial portal blood in ovariectomized thyroidectomized rats. Neuroendocrinology 1994;59:202-207.
9. Dahl GE, Evans NP, Thrun LA, Karsh FJ: A central negative feedback action of thyroid hormones on thyrotropin-releasing hormone secretion. Endocrinology 1994;135:2392-2397.
10. Rondeel JMM, de Greef WJ, van der School P, Karels B, Klootwijk W, Visser TJ: Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood. Endocrinology 1988;123:523-527.
11. Taylor T, Wondisford FE, Blaine T, Weintraub BD: The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion. Endocrinology 1990;126:317-324.
12. Blake NG, Eckland JA, Foster OJF, Lightman SL: Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology 1991; 129:2714-2718.
13. Shi ZX, Levy A, Lightman SL: The effect of dietary protein on thyrotropin-releasing hormone and thyrotropin gene expression. Brain Res 1993;606:1-4.
14. Rondeel JMM, Heide R, de Greef WJ, Van Toor H, van Haasteren GAC, Klootwijk W, Visser TJ: Effect of starvation and subsequent refeeding on thyroid function and release of hypothalamic thyrotropin-releasing hormone. Neuroendocrinology 1992;56:348-353.
15. van Haasteren GAC, Linkels E, van Toor H, Rondeel JMM, Themmen APN, deJong FH, Valentijn K, Vaudry H, Bauer K, Visser TJ, deGreef WJ: Starvation-induced changes in the hypothalamic content of prothyrotropin-releasing hormone (proTRH) mRNA and the hypothalamic release of proTRH-derived peptides: Role of the adrenal gland. J Endocrinol 1995;145:143-153.
16. Campbell GA, Kurcz M, Marshall S, Meites J: Effects of starvation in rats on serum levels of follicle stimulating hormone, luteinizing hormone, thyrotropin, growth hormone and prolactin: Response to LH-releasing hormone and thyrotropin-releasing hormone. Endocrinology 1977;100:580-587.
17. Harris RC, Fang S-L, Azizi F, Lipworth L, Vagenakis AG, Braverman LE: Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 1978;27:1074-1083.
18. Kinlaw WB, Schwartz HL, Oppenheimer JL: Decreased serum triiodothyronine in starving rats is due primarily to diminished thyroidal secretion of thyroxine. J Clin Invest 1985;75: 1238-1241.
19. Connors JM, DeVito W, Hedge GA: Effects of food deprivation on the feedback regulation of the hypothalamic-pituitary-thyroid axis of the rat. Endocrinology 1985;117:900-906.
20. Hugues JN, Epelbaum J, Voirol MJ, Modigliani E, Sebaoun J, Enjalbert A: Influence of starvation on hormonal control of hypophyseal secretion in rats. Acta Endocrinol 1988;119: 195-202.
21. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM: Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997;138:2569-2576.
22. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV: Leptin: The tale of an obesity gene. Diabetes 1996;45:1455-1462.
23. Bray GA, York DA: Leptin and clinical medicine: A new piece in the puzzle of obesity. J Clin Endocrinol Metab 1997:82:2771-2776.
24. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
25. Baker RA, Herkenham M: Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: Neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 1995;358:518-530.
26. Schwartz MW, Seeley RJ, Campfield A, Burn A, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101-1106.
27. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P: Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypotalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996;387:113-116.
28. Huang XF, Koutcherov I, Lin S, Wang HQ, Starlien L: Localization of leptin receptor mRNA expression in mouse brain. Neuroreport 1996;7:2635-2638.
29. Hakansson ML, Hulting AL, Meister B: Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus: Relationship with NPY neurons. Neuroreport 1996;7:3087-3092.
30. Fei H, Okano HJ, Li C, Lee CH, Zhao C, Darnell R, Friedman JM: Anatomic localization of alternatively spliced leptin receptor (OB-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997;94:7001-7005.
31. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B: Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 1997;273:E202-E206.
32. Kerkerian L, Pelletier G: Effects of monosodium L-glutamate administration on neuropeptide Y-containing neurons in the rat hypothalamus. Brain Res 1986;369:388-390.
33. Kakucska I, Qi Y, Clark BD, Lechan RM: Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 1993;133: 815-821.
34. Castro MI, Alex S, Young RA, Braverman LE, Emerson CH: Total and free serum thyroid hormone concentrations in fetal and adult pregnant and nonpregnant guinea pigs. Endocrinolology 1986;118:533-537.
35. Boden G, Chen X, Mozzoli M, Ryan I: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996;81:3419-3423.
36. Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF: Responses of leptin to short-term fasting and refeeding in humans. Diabetes 1996; 45:1511-1515.
37. Frederich RC, Lollmann B, Haman A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS: Expression of ob mRNA and its encoded protein in rodents: Impact of nutrition and obesity. J Clin Invest 1995;96:1658-1663.
38. Olney JW: Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-721.
39. Lemkey-Johnston N, Reynolds WA: Nature and extent of brain lesions in mice related to ingestion of monosodium glutamate. J Neuropathol Exp Neurol 1974;33:74-97.
40. Holzwarth-McBride MA, Hurst EM, Knigge KM: Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence. Anat Rec 1976;186:185-196.
41. Simson EL, Gold RM, Standish LJ, Pellett PL: Axon-sparing brain lesioning technique: The use of monosodium-L-glutamate and other amino acids. Science 1977;198:515-517.
42. Redding TW, Schally A, Arimura A, Wakabayashi I: Effect of monosodium glutamate on some endocrine functions. Neuroendocrinology 1971;8:245-255.
43. Millard WJ, Martin JB Jr, Audet J, Sager SM: Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 1982;110:540-550.
44. Bakke JL, Lawrence N, Bennett J, Robinson S, Bowers CY: Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology 1978;26:220-228.
45. Ribeiro EB, Oiler do Nascimento CM, Andrade IS, Hirata AE, Dolnikoff MS: Hormonal and metabolic adaptations to fasting in monosodium glutamate-obese rats. J Comp Physiol B 1997;167:430-437.
46. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P: Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996;8:733-735.
47. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-572.
48. Legradi G, Lechan RM: The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 1998;139:3262-3270.
49. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNAs in food restricted and food-deprived rats. Neuroendocrinology 1990;52: 441-447.
50. Sanacora G, Kershaw M, Finkelstein JA, White JD: Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990;127:730-737.
51. Stephens TW, Bristow PK, Bue-Valleskey JM, Burgett SG, Creft L, Hale J, Hoffman J, Hsiung HM, Kriaciunas A, MacKellar W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
52. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;3:44-50.
53. Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD: Endocrine function of neuropeptide Y knockout mice. Regul Pept 1997;70: 199-202.
54. Meister B, Ceccatelli S, Hokfelt T, Anden N-E, Anden M, Theodorsson E: Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: Effects of monosodium glutamate (MSG) lesions. Exp Brain Res 1989;76:343-368.
55. Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492.
56. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield A, Burn P, Baskin DG: Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123.
57. Thornton JE, Cheung C, Clifton DK, Steiner RA: Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-5066.
58. Bergendahl M, Wiemann JN, Clifton DK, Steiner RA: Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology 1992;56:913-920.
59. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-168.
60. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4-receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1289-1308.
61. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects. Nature 1997;390:349.
62. Huszar D, Lynch C, Fairchild-Huntress V, Dunmore J, Fang Q, Berkemier L, Gu W, Kesterson R, Boston B, Cone R, Smith F, Campfield L, Burn P, Lee F: Targeted disruption of the melanocortin-4-receptor results in obesity in mice. Cell 1997;88:131-141.
63. Liao N, Buland M, Nicolas P, Vaudry H, Pelletier G: Anatomical interactions of proopiomelanocortin (POMC)-related peptides, neuropeptide Y (NPY) and dopamine beta-hydroxylase (D beta H) fibers and thyrotropin-releasing hormone (TRH) neurons in the paraventricular nucleus of rat hypothalamus. Neuropeptides 1991;18:63-67.
64. Guy J, Vaudry H, Pelletier G: Differential projections of two immunoreactive alpha-melanocyte stimulating hormone (alpha-MSH) neuronal systems in the rat brain. Brain Res 1981; 220:199-202.
65. Cobb WE, Reichlin S, Jackson IMD: Growth hormone secretory status is a determinant of the thyrotropin response to thyrotropin-releasing hormone in euthyroid patients with hypothalamic-pituitary disease. J Clin Endocrinol Metab 1981;52:324-329.
66. Scanlon MF, Rodriguez-Arnao MD, Pourmand DJ, Weightman DR, Lewis M, Hall R: Catecholaminergic interactions in the regulation of thyrotropin (TSH) secretion in man. J Endocrinol Invest 1980;3:125-129.
67. Liao N, Vaudry H, Pelletier G: Neuroanatomical connections between corticotropin-releasing factor (CRF) and somatostatin (SRIF) nerve endings and thyrotropin-releasing hormone (TRH) neurons in the paraventricular nucleus of rat hypothalamus. Peptides 1992; 13:677-680.
68. Hirooka Y, Hollander CS, Suzuki S, Ferdinand P, Juan S-I: Somatostatin inhibits release of thyrotropin releasing factor from organ cultures of rat hypothalamus. Proc Natl Acad Sci USA 1978;75:4509-4513.
69. +-induced thyrotropin-releasing hormone release from superfused mediobasal hypothalami in rats: Inhibition by somatostatin. Neurosci Lett 1984;45:47-52.
70. Larsen PJ, Mikkelsen JD, Jessop D, Lightman SL, Chowdrey HS: Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axis. J Endocrinol 1994; 141:497-503.